子宮内膜症の疫学予測

◆英語タイトル:Endometriosis- Epidemiology Forecast
◆商品コード:DELV803006
◆発行会社(リサーチ会社):DelveInsight
◆発行日:2018年3月
◆ページ数:50
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2営業日以内)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥357,500見積依頼/購入/質問フォーム
Site Price(同一事業所内共有可)USD6,500 ⇒換算¥715,000見積依頼/購入/質問フォーム
Enterprise Price(同一法人内共有可)USD9,750 ⇒換算¥1,072,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はDelveInsight社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

DelveInsight’s ‘Endometriosis – Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Endometriosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2027

Endometriosis Epidemiology
The Endometriosis epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Endometriosis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Endometriosis Epidemiology Segmentation
The disease epidemiology covered in the report is segmented by total prevalence, diagnosed population and treatable cases of Endometriosis in 7MM.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the prevalent cases of Endometriosis in 7 major markets was 13.8 Million in 2016 and, is expected to increase at a significant growth rate during the study period i.e., 2016-2027. Among 7MM United States account for highest incident population of Endometriosis i.e., 7.4 Million followed by United Kingdom.

Report Scope
• The report covers detailed overview of Endometriosis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of Endometriosis
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by total prevalence of Endometriosis, Diagnosed cases as well as treatable population of Endometriosis in 7MM

Key strengths
• 10 Year Forecast of Endometriosis epidemiology
• 7MM Coverage
• Total Prevalent Cases of Endometriosis
• Diagnosed and Treatable population of Endometriosis in 7MM

Key assessments
• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

【レポートの目次】

1. Report Introduction
2. Disease Background and Overview: Endometriosis
2.1. Introduction
2.2. Stages
2.3. Types
2.4. Pathophysiology
2.5. Risk Factors
2.6. Diagnosis
2.7. Treatment
2.7.1. Laparoscopy
2.7.2. Laparotomy
2.7.3. Hysterectomy
3. Epidemiology of Endometriosis in 7MM
3.1. Key Findings
3.2. Population and Forecast Parameters
3.3. United States
3.3.1. Prevalent Cases of Endometriosis in the US (2016-2027)
3.3.2. Diagnosed population of Endometriosis in the US (2016-2027)
3.3.3. Treatable cases of Endometriosis in the US (2016-2027)
3.4. EU5
3.4.1. United Kingdom
3.4.1.1. Prevalent Cases of Endometriosis in the UK (2016-2027)
3.4.1.2. Diagnosed population of Endometriosis in the UK (2016-2027)
3.4.1.3. Treatable cases of Endometriosis in the UK (2016-2027)
3.4.2. Germany
3.4.2.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
3.4.2.2. Diagnosed population of Endometriosis in Germany (2016-2027)
3.4.2.3. Treatable cases of Endometriosis in Germany (2016-2027)
3.4.3. France
3.4.3.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
3.4.3.2. Diagnosed population of Endometriosis in Germany (2016-2027)
3.4.3.3. Treatable cases of Endometriosis in Germany (2016-2027)
3.4.4. Italy
3.4.4.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
3.4.4.2. Diagnosed population of Endometriosis in Germany (2016-2027)
3.4.4.3. Treatable cases of Endometriosis in Germany (2016-2027)
3.4.5. Spain
3.4.5.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
3.4.5.2. Diagnosed population of Endometriosis in Germany (2016-2027)
3.4.5.3. Treatable cases of Endometriosis in Germany (2016-2027)
3.5. Japan
3.5.1. Prevalent Cases of Endometriosis in Germany (2016-2027)
3.5.2. Diagnosed population of Endometriosis in Germany (2016-2027)
3.5.3. Treatable cases of Endometriosis in Germany (2016-2027)
4. Treatment Algorithm
4.1. Initial Treatment
4.2. Treatment of Recurrent Endometriosis
4.3. Add-Back Therapy
5. Current Unmet Needs
6. Appendix
7. Report Methodology
7.1. Sources Used
8. DelveInsight Capabilities
9. Disclaimer
10. About DelveInsight

Table 1 : Prevalent Cases of Endometriosis in United States (2016-2027)
Table 2 : Diagnosed Population of Endometriosis in United States (2016-2027)
Table 3 : Treatable Cases of Endometriosis in United States (2016-2027)
Table 4 : Prevalent Cases of Endometriosis in Germany (2016-2027)
Table 5 : Diagnosed Population of Endometriosis in Germany (2016-2027)
Table 6 : Treatable Cases of Endometriosis in Germany (2016-2027)
Table 7 : Prevalent Cases of Endometriosis in France (2016-2027)
Table 8 : Diagnosed Population of Endometriosis in France (2016-2027)
Table 9 : Treatable Cases of Endometriosis in France (2016-2027)
Table 10 : Prevalent Cases of Endometriosis in Italy (2016-2027)
Table 11 : Diagnosed Population of Endometriosis in Italy (2016-2027)
Table 12 : Treatable Cases of Endometriosis in Italy (2016-2027)
Table 13 : Prevalent Cases of Endometriosis in Spain (2016-2027)
Table 14 : Diagnosed Population of Endometriosis in Spain (2016-2027)
Table 15 : Treatable Cases of Endometriosis in Spain (2016-2027)
Table 16 : Prevalent Cases of Endometriosis in United Kingdom (2016-2027)
Table 17 : Diagnosed Population of Endometriosis in United Kingdom (2016-2027)
Table 18 : Treatable Cases of Endometriosis in United Kingdom (2016-2027)
Table 19 : Prevalent Cases of Endometriosis in Japan (2016-2027)
Table 20 : Diagnosed Population of Endometriosis in Japan (2016-2027)
Table 21 : Treatable Cases of Endometriosis in Japan (2016-2027)


Figure 1 : Prevalent Cases of Endometriosis in United States (2016-2027)
Figure 2 : Diagnosed Population of Endometriosis in United States (2016-2027)
Figure 3 : Treatable Cases of Endometriosis in United States (2016-2027)
Figure 4 : Prevalent Cases of Endometriosis in Germany (2016-2027)
Figure 5 : Diagnosed Population of Endometriosis in Germany (2016-2027)
Figure 6 : Treatable Cases of Endometriosis in Germany (2016-2027)
Figure 7 : Prevalent Cases of Endometriosis in France (2016-2027)
Figure 8 : Diagnosed Population of Endometriosis in France (2016-2027)
Figure 9 : Treatable Cases of Endometriosis in France (2016-2027)
Figure 10 : Prevalent Cases of Endometriosis in Italy (2016-2027)
Figure 11 : Diagnosed Population of Endometriosis in Italy (2016-2027)
Figure 12 : Treatable Cases of Endometriosis in Italy (2016-2027)
Figure 13 : Prevalent Cases of Endometriosis in Spain (2016-2027)
Figure 14 : Diagnosed Population of Endometriosis in Spain (2016-2027)
Figure 15 : Treatable Cases of Endometriosis in Spain (2016-2027)
Figure 16 : Prevalent Cases of Endometriosis in United Kingdom (2016-2027)
Figure 17 : Diagnosed Population of Endometriosis in United Kingdom (2016-2027)
Figure 18 : Treatable Cases of Endometriosis in United Kingdom (2016-2027)
Figure 19 : Prevalent Cases of Endometriosis in Japan (2016-2027)
Figure 20 : Diagnosed Population of Endometriosis in Japan (2016-2027)
Figure 21 : Treatable Cases of Endometriosis in Japan (2016-2027)


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 子宮内膜症の疫学予測(Endometriosis- Epidemiology Forecast )]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆